Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractButyrate, the four-carbon fatty acid, is formed in the human colon by bacterial fermentation of carbohydrates (including dietary fiber), and putatively suppresses colorectal cancer (CRC). Butyrate has diverse and apparently paradoxical effects on cellular proliferation, apoptosis and differentiation that may be either pro-neoplastic or anti-neoplastic, depending upon factors such as the level of exposure, availability of other metabolic substrate and the intracellular milieu. In humans, the relationship between luminal butyrate exposure and CRC has been examined only indirectly in case-control studies, by measuring fecal butyrate concentrations, although this may not accurately reflect effective butyrate exposure during carcinogenesis. Perhaps not surprisingly, results of these investigations have been mutually contradictory. The direct effect of butyrate on tumorigenesis has been assessed in a number of in vivo animal models, which have also yielded conflicting results. In part, this may be explained by methodological differences in the amount and route of butyrate administration, which are likely to significantly influence delivery of butyrate to the distal colon. Nonetheless, there appears to be some evidence that delivery of an adequate amount of butyrate to the appropriate site protects against early tumorigenic events. Future study of the relationship between butyrate and CRC in humans needs to focus on risk stratification and the development of feasible strategies for butyrate delivery.
CitationJ. Gastroenterol. Hepatol. 2006, 21 (1 Pt 2):209-218
DescriptionKEYWORDS - CLASSIFICATION: Animals;Anticarcinogenic Agents;Butyrates;Cell Proliferation;Colon;Colorectal Neoplasms;dietary modulation of cancer & cancer biomarkers;drug effects;Dietary Fiber;Evaluation;Humans;mechanisms of carcinogenesis;metabolism;pathology;pharmacology;physiopathology;prevention & control.
- A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate.
- Authors: Fung KY, Cosgrove L, Lockett T, Head R, Topping DL
- Issue date: 2012 Sep
- Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics.
- Authors: Pool-Zobel BL, Selvaraju V, Sauer J, Kautenburger T, Kiefer J, Richter KK, Soom M, Wölfl S
- Issue date: 2005 Jun
- Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis.
- Authors: McMillan L, Butcher S, Wallis Y, Neoptolemos JP, Lord JM
- Issue date: 2000 Jun 24
- Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre.
- Authors: Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, Miene C, Munjal U, Stein K, Glei M
- Issue date: 2009 Jul-Aug
- The importance of colonic butyrate transport to the regulation of genes associated with colonic tissue homoeostasis.
- Authors: Daly K, Cuff MA, Fung F, Shirazi-Beechey SP
- Issue date: 2005 Aug